527 related articles for article (PubMed ID: 37052341)
21. Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018.
Song Y; Guo W; Li Z; Guo D; Li Z; Li Y
Front Immunol; 2022; 13():1058779. PubMed ID: 36466832
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
[TBL] [Abstract][Full Text] [Related]
23. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD.
Dong W; Gong Y; Zhao J; Wang Y; Li B; Yang Y
Front Endocrinol (Lausanne); 2023; 14():1281839. PubMed ID: 38260163
[TBL] [Abstract][Full Text] [Related]
24. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
Kim D; Vazquez-Montesino LM; Escober JA; Fernandes CT; Cholankeril G; Loomba R; Harrison SA; Younossi ZM; Ahmed A
Am J Gastroenterol; 2020 Sep; 115(9):1496-1504. PubMed ID: 32496342
[TBL] [Abstract][Full Text] [Related]
25. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease.
Kim D; Murag S; Cholankeril G; Cheung A; Harrison SA; Younossi ZM; Ahmed A
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1240-1247.e5. PubMed ID: 32683103
[TBL] [Abstract][Full Text] [Related]
26. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease.
Charatcharoenwitthaya P; Karaketklang K; Aekplakorn W
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2393-2404. PubMed ID: 36017777
[TBL] [Abstract][Full Text] [Related]
27. Association of Systemic Immune-Inflammation Index With Stroke and Mortality Rates: Evidence From the NHANES Database.
Yang L; Wang M
Neurologist; 2024 Feb; ():. PubMed ID: 38409948
[TBL] [Abstract][Full Text] [Related]
28. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
[TBL] [Abstract][Full Text] [Related]
29. Association between systemic inflammatory indicators with the survival of chronic kidney disease: a prospective study based on NHANES.
Chen Y; Nie Y; Wu J; Li C; Zheng L; Zhu B; Min Y; Ling T; Liu X
Front Immunol; 2024; 15():1365591. PubMed ID: 38650947
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
31. Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction-associated fatty liver disease: a prospective cohort study.
Zhang JJ; Yu HC; Li Y; Zhang YB; Geng TT; Lu Q; Liao YF; Guo KQ; Du L; Ruan HL; Yang K; Liu G; Pan A
Am J Clin Nutr; 2022 Nov; 116(5):1409-1417. PubMed ID: 36107812
[TBL] [Abstract][Full Text] [Related]
32. Nonlinear association of the systemic immune-inflammatory index with mortality in diabetic patients.
Meng C; Liu K
Front Endocrinol (Lausanne); 2024; 15():1334811. PubMed ID: 38414824
[TBL] [Abstract][Full Text] [Related]
33. The association of systemic inflammatory biomarkers with non-alcoholic fatty liver disease: a large population-based cross-sectional study.
Sun W; Fang Y; Zhou B; Mao G; Cheng J; Zhang X; Liu Y; Chen H
Prev Med Rep; 2024 Jan; 37():102536. PubMed ID: 38186662
[TBL] [Abstract][Full Text] [Related]
34. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
[TBL] [Abstract][Full Text] [Related]
35. Validation and Comparison of Two Dietary Indexes for Predicting Nonalcoholic Fatty Liver Disease in US Adults.
Li R; Chen Z
J Nutr; 2023 Jan; 152(12):2865-2876. PubMed ID: 36190320
[TBL] [Abstract][Full Text] [Related]
36. Association of Systemic Immune-Inflammation Index with Non-Alcoholic Fatty Liver Disease: A Population-Based Cross-Sectional Study.
Zhao B; Liu Y; Yang Y; He J
Risk Manag Healthc Policy; 2023; 16():1581-1592. PubMed ID: 37605743
[TBL] [Abstract][Full Text] [Related]
37. Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study.
Ye C; Yuan L; Wu K; Shen B; Zhu C
BMC Pulm Med; 2023 Aug; 23(1):295. PubMed ID: 37563621
[TBL] [Abstract][Full Text] [Related]
38. Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease.
Wu W; Xiang J; Chen X
Front Endocrinol (Lausanne); 2021; 12():773342. PubMed ID: 34992579
[TBL] [Abstract][Full Text] [Related]
39. Association of systemic immune inflammatory index with all-cause and cause-specific mortality among individuals with type 2 diabetes.
Chen C; Chen Y; Gao Q; Wei Q
BMC Cardiovasc Disord; 2023 Dec; 23(1):596. PubMed ID: 38057733
[TBL] [Abstract][Full Text] [Related]
40. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999-2018.
Liu B; Wang J; Li YY; Li KP; Zhang Q
Arthritis Res Ther; 2023 Mar; 25(1):34. PubMed ID: 36871051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
